ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO559

Proteomic Analysis of Glomerular Extracellular Matrix Suggests a Potential Role of Complement in the Pathogenesis of Idiopathic Collapsing Glomerulopathy Associated with APOL1 High-Risk Genotypes

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Neves, Precil D., Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Siqueira, Talita Souza, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Feitosa, Valkercyo Araújo, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Watanabe, Andreia, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Watanabe, Elieser H., Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Castelli, Jussara Bianchi, Fleury Laboratory, São Paulo, Brazil
  • Gonçalves, Natalia Gomes, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Lin, Chin Jia, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Cavalcante, Livia Barreira, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Malheiros, Denise M., Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Jorge, Lectícia, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Noronha, Irene L., Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
  • Carvalho, Valdemir Melechco, Fleury Laboratory, São Paulo, Brazil
  • Onuchic, Luiz F., Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo, São Paulo, Brazil
Background

The pathogenesis of collapsing glomerulopathy (CG), a highly aggressive nephropathy, remains largely unclear. While a significant fraction of idiopathic CG (ICG) cases is associated with APOL1 high-risk genotypes (HRG), the differences in pathogenic processes between ICG associated with HRG (ICG+HRG) and with APOL1 low-risk genotypes (ICG+LRG) are still poorly characterized.

Methods

To identify novel potential differences in molecular pathogenic pathways between ICG+HRG and ICG+LRG, we performed proteomic analyses of glomerular extracellular matrix (ECM) in 4 groups of patients: ICG+HRG (9 cases); non-Mendelian ICG+LRG (8 cases); FSGS-NOS+LRG (5 cases, a disease profile control); and normal kidney tissue (NK, 6 cases, a baseline control obtained from non-affected areas of nephrectomies secondary to malignancy). Glomerular samples were acquired by laser-microdissection. The relative abundance of proteins was compared between groups.

Results

We identified 931 proteins present in at least 60% of the samples of one group. Two hundred of them were classified as ECM proteins. C1QC, CFHR1, and hornerin were detected exclusively in the ICG+HRG group while laminin alpha 2 was detected only in the ICG+LRG group. Moreover, annexin A4, C5, C9, C4b-binding protein alpha chain (C4BPA), Serpin Family B Member 6 (SERPINB6), SERPINB9, and SERPINC1 stood out as displaying greater abundance in ICG+HRG than NK, and C4BPA, COL4A4, COL4A5, laminin beta 2, and nidogen-1 as presenting more abundance in ICG+HRG than FSGS-NOS+LRG. Annexin A4, annexin A6, SERPINB9 and SERPINH1 stood out as displaying greater abundance in ICG+LRG than NK. No difference in abundance was detected between ICG+HRG and ICG+LRG.

Conclusion

Our data showed that ICG+HRG and ICG+LRG presented patterns of glomerular ECM proteins associated with inflammation, immune activation and fibrosis pathways, and suggested a potential involvement of the complement system in the pathogenesis of ICG+HRG.